{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:25:10Z","timestamp":1792110310737,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Concrete, data-driven guidelines for breast cancer screening among the transgender and gender diverse (TGD) population is lacking. The present study evaluates possible associations of gender-affirming hormone therapy (GAHT) on incidental breast pathology findings in trans-masculine patients to inform decision making about breast cancer screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study of patients who had gender-affirming mastectomy or breast reduction at a single center from July 2019 to February 2024. A total of 865 patients met the inclusion criteria.\u00a0Gender-affirming testosterone therapy and length of exposure were evaluated to seek differences in post-operative pathology findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age at the time of surgery was 27 years [interquartile range (IQR) 21\u201330]. Most participants identified as female to male (658, 75.6%). A significant portion of the participants (688, 79.2%) were undergoing testosterone therapy at the time of surgery, with the median duration of testosterone use prior to surgery being 14 months (IQR 4\u201329). High risk or malignant findings were noted in pathology results for 12 of 1730 breasts (0.7%). Ordered logistic regression found that duration of testosterone therapy was not associated with increasing severity of incidental breast pathology. Additionally, patients under 25 years of age were 70% less likely to have any incidental finding on pathological evaluation than older patients [odds ratio (OR) 0.3, <jats:italic>p<\/jats:italic> &lt; 0.01, confidence interval (CI) 0.18\u20130.50].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study found that patients undergoing GAHT should not be screened for breast cancer with increased frequency compared with cis-gender women. Additionally, it may be appropriate for trans women under the age of 25 with normal breast cancer risk to forego pathological breast tissue examination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-16005-1","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T13:04:29Z","timestamp":1723035869000},"page":"8086-8092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence of High Risk and Malignant Pathological Findings in Transgender and Gender Diverse Individuals Undergoing Gender-Affirming Mastectomy"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-479X","authenticated-orcid":false,"given":"Rachel L.","family":"McCaffrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Torres-Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamin K.","family":"Addae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elianna","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe R.","family":"Finer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E.","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam","family":"Al-Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"16005_CR1","unstructured":"Brown A. About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth. Pew Res."},{"issue":"2","key":"16005_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","volume":"107","author":"EL Meerwijk","year":"2017","unstructured":"Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1\u20138. https:\/\/doi.org\/10.2105\/AJPH.2016.303578.","journal-title":"Am J Public Health."},{"key":"16005_CR3","unstructured":"American Society of Plastic Surgeons. Plastic Surgery Statistics Report. https:\/\/www.plasticsurgery.org\/documents\/News\/Statistics\/2020\/plastic-surgery-statistics-full-report-2020.pdf"},{"issue":"3","key":"16005_CR4","doi-asserted-by":"publisher","first-page":"NP209","DOI":"10.1093\/asj\/sjad353","volume":"44","author":"RK Das","year":"2024","unstructured":"Das RK, Galdyn I, McCaffrey RL, Drolet BC, Al Kassis S. Geographic differences in patient demographics and performance of gender-affirming surgery from 2016 to 2019. Aesthet Surg J. 2024;44(3):NP209\u201317. https:\/\/doi.org\/10.1093\/asj\/sjad353.","journal-title":"Aesthet Surg J"},{"issue":"1","key":"16005_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41379-020-00675-9","volume":"34","author":"GM Baker","year":"2021","unstructured":"Baker GM, Guzman-Arocho YD, Bret-Mounet VC, et al. Testosterone therapy and breast histopathological features in transgender individuals. Mod Pathol. 2021;34(1):85\u201394. https:\/\/doi.org\/10.1038\/s41379-020-00675-9.","journal-title":"Mod Pathol."},{"key":"16005_CR6","doi-asserted-by":"publisher","first-page":"l1652","DOI":"10.1136\/bmj.l1652","volume":"365","author":"CJM de Blok","year":"2019","unstructured":"de Blok CJM, Wiepjes CM, Nota NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:l1652. https:\/\/doi.org\/10.1136\/bmj.l1652.","journal-title":"BMJ"},{"issue":"6","key":"16005_CR7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/00006534-199905060-00015","volume":"103","author":"MH Brown","year":"1999","unstructured":"Brown MH, Weinberg M, Chong N, Levine R, Holowaty E. A cohort study of breast cancer risk in breast reduction patients. Plast Reconstr Surg. 1999;103(6):1674\u201381. https:\/\/doi.org\/10.1097\/00006534-199905060-00015.","journal-title":"Plast Reconstr Surg."},{"issue":"5","key":"16005_CR8","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1200\/OP.22.00681","volume":"19","author":"D Roznovjak","year":"2023","unstructured":"Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS. Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract. 2023;19(5):e794\u2013800. https:\/\/doi.org\/10.1200\/OP.22.00681.","journal-title":"JCO Oncol Pract."},{"issue":"1","key":"16005_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","volume":"149","author":"GR Brown","year":"2015","unstructured":"Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191\u20138. https:\/\/doi.org\/10.1007\/s10549-014-3213-2.","journal-title":"Breast Cancer Res Treat."},{"key":"16005_CR10","unstructured":"American College of Radiology. American College of Radiology ACR Appropriateness Criteria\u00ae Transgender Breast Cancer Screening. https:\/\/acsearch.acr.org\/docs\/3155692\/Narrative\/"},{"issue":"4","key":"16005_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/PRS.0b013e3181b45801","volume":"124","author":"CJ Clark","year":"2009","unstructured":"Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124(4):1033\u20139. https:\/\/doi.org\/10.1097\/PRS.0b013e3181b45801.","journal-title":"Plast Reconstr Surg."},{"issue":"3","key":"16005_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5114\/pm.2015.54346","volume":"14","author":"M Kaminska","year":"2015","unstructured":"Kaminska M, Ciszewski T, Lopacka-Szatan K, Miotla P, Staroslawska E. Breast cancer risk factors. Prz Menopauzalny. 2015;14(3):196\u2013202. https:\/\/doi.org\/10.5114\/pm.2015.54346.","journal-title":"Prz Menopauzalny."},{"key":"16005_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2020.06.008","volume":"53","author":"AC Fledderus","year":"2020","unstructured":"Fledderus AC, Gout HA, Ogilvie AC, van Loenen DKG. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast. 2020;53:92\u2013100. https:\/\/doi.org\/10.1016\/j.breast.2020.06.008.","journal-title":"Breast."},{"issue":"4 Suppl 4","key":"16005_CR14","doi-asserted-by":"publisher","first-page":"S332","DOI":"10.1097\/SAP.0000000000003083","volume":"88","author":"N Parmeshwar","year":"2022","unstructured":"Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Ann Plast Surg. 2022;88(4 Suppl 4):S332\u20136. https:\/\/doi.org\/10.1097\/SAP.0000000000003083.","journal-title":"Ann Plast Surg."},{"issue":"3 Suppl 3","key":"16005_CR15","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/SAP.0000000000003175","volume":"88","author":"MK Bruce","year":"2022","unstructured":"Bruce MK, Joseph WJ, Grunwaldt L, Nguyen VT, De La Cruz C. Transgender mastectomy: incidence of high-risk pathologic findings and the need for postoperative cancer surveillance. Ann Plast Surg. 2022;88(3 Suppl 3):S148\u201351. https:\/\/doi.org\/10.1097\/SAP.0000000000003175.","journal-title":"Ann Plast Surg."},{"issue":"1","key":"16005_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/PRS.0000000000007452","volume":"147","author":"A Jacoby","year":"2021","unstructured":"Jacoby A, Rifkin W, Zhao LC, Bluebond-Langner R. Incidence of cancer and premalignant lesions in surgical specimens of transgender patients. Plast Reconstr Surg. 2021;147(1):194\u20138. https:\/\/doi.org\/10.1097\/PRS.0000000000007452.","journal-title":"Plast Reconstr Surg."},{"issue":"5","key":"16005_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1097\/PRS.0b013e3181d5139e","volume":"125","author":"PF Koltz","year":"2010","unstructured":"Koltz PF, Girotto JA. The price of pathology: is screening all breast reduction specimens cost effective? Plast Reconstr Surg. 2010;125(5):1575\u20136. https:\/\/doi.org\/10.1097\/PRS.0b013e3181d5139e.","journal-title":"Plast Reconstr Surg."},{"issue":"8","key":"16005_CR18","doi-asserted-by":"publisher","first-page":"e2330348","DOI":"10.1001\/jamanetworkopen.2023.30348","volume":"6","author":"JD Wright","year":"2023","unstructured":"Wright JD, Chen L, Suzuki Y, Matsuo K, Hershman DL. National estimates of gender-affirming surgery in the US. JAMA Netw Open. 2023;6(8):e2330348. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.30348.","journal-title":"JAMA Netw Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16005-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:08:45Z","timestamp":1728569325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16005-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["16005"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16005-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}